• Explore /
  • Poster
  • / Incidence of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients (pts) with a germline (g) <em>BRCA </em>mutation (m) and platinum-sensitive relapsed ovarian cancer (PSR OC) receiving maintenance olaparib in SOLO2: Impact of prior lines of platinum therapy.

Incidence of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients (pts) with a germline (g) BRCA mutation (m) and platinum-sensitive relapsed ovarian cancer (PSR OC) receiving maintenance olaparib in SOLO2: Impact of prior lines of platinum therapy.

Abstract Poster

Authors

null

Jacob Korach

Sheba Medical Center, Tel Aviv University, Tel Hashomer, Israel

Jacob Korach , Simon Turner , Tsveta Milenkova , Iulian Alecu , Emma McMurtry , Ralph Bloomfield , Eric Pujade-Lauraine

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT01874353

Citation

J Clin Oncol 36, 2018 (suppl; abstr 5548)

DOI

10.1200/JCO.2018.36.15_suppl.5548

Abstract #

5548

Poster Bd #

275

Abstract Disclosures

Similar Posters

First Author: Andres Poveda

First Author: Angelina Tjokrowidjaja

First Author: Andres Poveda

First Author: Sandro Pignata